Drug Trial Radar · NCT07266402
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Jan 15, 2026
Primary completion
Jun 2028
Study completion Oct 2028
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.
Conditions
- Chronic Inducible Urticaria
- Cold Urticaria
- Cold-Induced Urticaria
- Symptomatic Dermographism
Interventions
BarzolvolimabDrug
Subcutaneous Administration
Matching PlaceboDrug
Subcutaneous Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete response to provocation testing at Week 12Time frame: From Day 1 (first dose) to Week 12
Locations
72 sites in 7 countries. Site status is shown where the registry gives one.
Cahaba Dermatology & Skin Health Center, LLC
Birmingham, Alabama · Recruiting
One of a Kind Clinical Research Center, LLC
Scottsdale, Arizona · Recruiting
Kern Research, Inc.
Bakersfield, California · Recruiting
One of a Kind Clinical Research Center
Napa, California · Recruiting
Allergy & Asthma Consultants
Redwood City, California · Recruiting
Amicis Research Center
Sherman Oaks, California · Recruiting
FOMAT - Allergy, Asthma & Immunology Medical Group
Ventura, California · Recruiting
Direct Helpers Research Center
Hialeah, Florida · Recruiting
Well Pharma Medical Research, Corp.
Miami, Florida · Recruiting
Deluxe Health Center, LLC
Miami Lakes, Florida · Recruiting
GCP, Global Clinical Professionals
St. Petersburg, Florida · Recruiting
Advanced Clinical Research Institute
Tampa, Florida · Recruiting
Centricity Research Columbus Dermatology
Columbus, Georgia · Recruiting
Treasure Valley Medical Research
Boise, Idaho · Recruiting
Endeavor Health Clinical Trials Center
Skokie, Illinois · Recruiting
Equity Medical, LLC
Bowling Green, Kentucky · Recruiting
Advanced ENT and Allergy, PLLC
Louisville, Kentucky · Recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
Revival Research Institute, LLC
Troy, Michigan · Recruiting
Equity Medical, LLC
New York, New York · Recruiting
Markowitz Medical PLLC dba OptiSkin Medical
New York, New York · Recruiting
University of Cincinnati
Cincinnati, Ohio · Not yet recruiting
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma · Recruiting
Advanced Dermatology and Cosmetic Surgery - Spartanburg
Spartanburg, South Carolina · Recruiting
RFSA Dermatology
San Antonio, Texas · Recruiting
Allergy Associates of Utah
Sandy City, Utah · Recruiting
Universitätsklinikum Augsburg, Klinik für Dermatologie und Allergologie
Augsburg, Germany · Recruiting
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP Immunologie und Allergologie IA c/o Charité - Universitätsmedizin Berlin
Berlin, Germany · Recruiting
Elbe Kliniken Buxtehude Dermatologie
Buxtehude, Germany · Recruiting
Rosenpark Research GmbH
Darmstadt, Germany · Recruiting
Universitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Dermatologie
Dresden, Germany · Recruiting
Department of Dermatology, University Hospital Dusseldorf
Düsseldorf, Germany · Recruiting
Hautklinik, Uniklinkum Erlangen
Erlangen, Germany · Recruiting
Universitätsklinikum Göttingen -- George-August-Universitat Göttinggen, Klinik für Dermatoogie, Venerologie und Allergologie
Göttingen, Germany · Recruiting
Universitätsklinikum Heidelberg, Klinik für Dermatologie
Heidelberg, Germany · Recruiting
MVZ DermaKiel GmbH
Kiel, Germany · Recruiting
Universitätsklinikum Schleswig-Holstein Universität zu Lübeck - Campus Lübeck
Lübeck, Germany · Recruiting
Klinik und Poliklinik für Dermatologie und Allergologie, LMU Klinikum; DASZ-Dermato-Allergologisches Studienzentrum
München, Germany · Recruiting
Universitätsklinikum Münster, Klinik u. Poliklinik f. Dermatologie
Münster, Germany · Recruiting
Universitäts-Hautklinik Tübingen Studienzentrum Immundermatologie
Tübingen, Germany · Recruiting
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.